Optimizing derivatization conditions using an experimental design and simultaneous estimation of artemether and lumefantrine by ratio first order derivative spectrophotometric method  by Christian, Jenee et al.
JA
d
e
d
d
d
F
f
w
2
a
l
e
©
t
K
P
h
1
CARTICLE IN PRESS+ModelTUSCI-323; No. of Pages 12
Journal of Taibah University for Science xxx (2016) xxx–xxx
Available  online  at  www.sciencedirect.com
ScienceDirect
Optimizing derivatization conditions using an experimental design
and simultaneous estimation of artemether and lumefantrine by ratio
first order derivative spectrophotometric method
Jenee Christian, Purvi Shah ∗, Margi Patel, Kalpana Patel, Tejal Gandhi
Department of Quality Assurance, Anand Pharmacy College, Anand, Gujarat, India
Received 16 May 2016; received in revised form 13 July 2016; accepted 3 August 2016
bstract
Artemether–lumefantrine is the most widely used artemisinin-based combination therapy for malaria. The present work aims to
evelop and validate a simple, accurate, precise and rapid ratio first order derivative spectrophotometric method for the simultaneous
stimation of artemether and lumefantrine in a fixed dose combination tablet. The first step in development of the method was to
erivatize artemether. As artemether does not show absorption in the UV region, it was derivatized using hydrochloric acid as the
erivatizing agent. The derivatizing conditions were further optimized by full factorial multivariate approach, where the indepen-
ent variables were volume of concentrated hydrochloric acid and time taken for artemether derivatization at room temperature.
urthermore, based on the statistical analysis, derivatizing conditions were optimized i.e. 1.3 ml of conc. HCl at room temperature
or 30 min. At this condition, the artemether was found to absorb in the UV region satisfactorily, and the absorbance of lumefantrine
as found to remain unaffected. The developed method showed good calibration data in the range of 5–30 g/ml for artemether and
–12 g/ml for lumefantrine. The mean % recovery values were found to be 99.96–100.49% and 99.48–100.31% for artemether
nd lumefantrine, respectively. Additionally, the developed method was effectively applied in the estimation of artemether and
umefantrine in a commercial tablet (ARH-L DS tablets), suggesting that it can be practically applied for quality control of routinely
xamined drugs in combined dosage forms with the reduced expenditure of time.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of Taibah University. This is an open access article under
he CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1.  Introduction
Malaria is a leading global cause of morbidity and
mortality. According to the latest estimates, released in
December 2014 by WHO, there were approximately
198 million cases of malaria in 2013 and an esti-
mated 584,000 deaths. The children living in Africaderivatization conditions using an experimental design and
first order derivative spectrophotometric method, J. Taibah
behalf of Taibah University. This is an open access article under the
are on the verge of great danger, where a child dies
every minute from malaria. Currently, the main pil-
lars for the treatment of malaria and for slowing
ARTICLE IN PRESS+ModelJTUSCI-323; No. of Pages 12
2 J. Christian et al. / Journal of Taibah University for Science xxx (2016) xxx–xxx
f (a) ArFig. 1. Chemical structure o
the spread of resistance are such drugs as chloro-
quine and sulfadoxine–pyrimethamine, a non-alkaloidal
artemisinin-type antimalarial drug (artemisinin and its
derivatives), as well as combinations of other drugs.
Additionally, WHO recommends use of artemisinin-
based combination treatments (ACT) as first line therapy
in treatment of acute uncomplicated Plasmodium falci-
parum malaria [1–3].
The combination of artemether and lumefantrine
tablets is a fixed-dose combination ACT therapy added
to the WHO Essential Medicines list in 2002. Artemether
(ARM) (decahydro-10- methoxy-3, 6, 9-trimethyl-
3, 12-epoxy-12H-pyrano [4.3-j]-1, 2- benzodioxepin)
(Fig. 1a) is more active than the parent compound
artemisinin. Artemether is practically insoluble in water,
very soluble in dichloromethane and acetone, and
freely soluble in ethyl acetate and dehydrated ethanol,
and it shows higher stability when dissolved in oils.
Lumefantrine (LUM) is a racemic fluorene derivative
with the chemical name (1RS)-2-(dibutylamino)-
1-{(9Z)-2, 7-dichloro-9-[(4-chlorophenyl)methylene]-
9H-fluorene-4-yl}ethanol (Fig. 1b) [4,5].
The quantification of ARM and LUM in commer-
cial pharmaceutical products is principally important
for both quality control and consumer safety. ARM
does not show any significant absorption in the effec-
tive wavelength region of the UV–visible spectroscopy
and also lacks specific chemical groups which can easily
react with certain reagents to yield coloured products.
The reviewed literature indicates that adding a chro-
mophoric group to artemether can be performed by acid
or base treatment converting it into more reactive com-
pounds, such as enolate/carboxylates or ,-unsaturated
decalones, and can cause absorption of UV radiation.
This transformation had been used as the basis forPlease cite this article in press as: J. Christian, et al. Optimizing 
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the determination of this drug in dosage forms using
spectrophotometry. The reaction between artemether
and hydrochloric acid is shown in Fig. 2 and involvestemether; (b) Lumefantrine.
rearrangement of groups and the addition of a free car-
boxylate group [6–13].
ARM is an official drug used in Indian Phar-
macopoeia, British Pharmacopoeia and United State
Pharmacopoeia [14–18], whereas LUM is official in USP
SALMOUS [18]. Several methods including UV and
HPLC, used for the estimation of ARM [19–27] while
UV, HPLC, HPTLC and tandem techniques used for the
estimation of LUM [28–32] have been described in pre-
vious literature. However, existing methods involving
the simultaneous estimation of ARM and LUM in phar-
maceutical dosage form focuses on chromatographic
techniques, i.e., HPLC and HPTLC [33–40]. Regard-
ing the simple and economical UV method, only one
method that is derivative of spectrophotometric analy-
sis has been reported, in which artemether is derivatized
using hydrochloric acid at 60 ±  2 ◦C, but the reaction
time reported is 3 h, making it time-consuming [13].
Hence, in the present study, an attempt was made to
establish derivatizing conditions for artemether while
reducing time investment and without affecting the
absorption property of lumefantrine in order to make it
a suitable candidate for concurrent estimation by ratio
first order derivative spectrophotometric method. In the
present study, an experimental approach was designed
for optimizing the derivatizing conditions and mini-
mizing the number of trials. Experimental design is the
multidimensional combination and interaction of input
variables (e.g., material attributes) and process param-
eters that have been demonstrated to provide assurance
of quality [41–43]. It is more efficient in multifactor
optimization because one factor at a time approach
(OFAT) can easily miss the optima, while the design of
experiment approach (DOE) is a powerful instrument
to generate, apply and interpret scientific experimentsderivatization conditions using an experimental design and
first order derivative spectrophotometric method, J. Taibah
in an effective way. It offers the maximum information
about how the factors influence the response evaluated
while requiring minimum investment of time, making it
ARTICLE IN PRESS+ModelJTUSCI-323; No. of Pages 12
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ossible to rank each independent variable according to
ts significance based on studied responses [44–50].
The aim of the present work was to employ an exper-
mental design approach for optimizing the derivatizing
onditions for artemether in the presence of lumefantrine
sing concentrated hydrochloric acid as the derivatiz-
ng reagent and to develop a validated, simple, rapid,
ensitive and reliable analytical method for the simul-
aneous determination of ARM and LUM in combined
harmaceutical dosage form.
.  Materials  and  methods
.1.  Materials
Analytically pure drug samples of ARM and
UM were obtained from Baroque Pharma-
euticals, Khambhat, India as a gift sample.
arketed tablet formulation used for the analy-
is was ARH-L DS tablet (Artemether 80 mg and
umefantrine 480 mg) manufactured by Lincoln
harmaceuticals Ltd., Ahmedabad, India procured from
he local market. All solvents and chemicals were of
nalytical grade and used without further purification.
.2.  Instruments  and  software
ARM and LUM quantification was performed using
ouble beam UV–visible spectrophotometer (Shimadzu
orporation, model UV 1800) having two matched
uartz cells with 1 cm optical pathlength in the wave-Please cite this article in press as: J. Christian, et al. Optimizing 
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ength range from 200 to 800 nm. Other equipment used
ncluded ultrasonic bath (Amkette Industries Pvt. Ltd.,
ndia) and electronic analytical balance (AUW 220, Shi-
adzu Corp. Japan). UV Probe Software version 2.35n artemether and hydrochloric acid [20].
(Shimadzu 1800, Japan) was used for method develop-
ment and validation of spectrophotometric method. Data
investigation of experimental design was performed by
the Design-Expert trial version 9.0.0.1 (Stat-Ease Inc.,
Minneapolis, USA) statistical software. The rest of the
calculations were performed with the help of Microsoft
Excel 2010 software (Microsoft Corporation, USA).
2.3.  Preparation  of  solutions  for  optimization  of
reaction conditions
An accurately weighed 50 mg of standard ARM and
LUM were transferred to two separate 50 ml volumetric
flasks, dissolved in 25 ml of methanol, and the volume
was increased to the mark with methanol for obtaining
1000 g/ml stock solution. Furthermore, 25 ml of stock
solution was diluted to 50 ml with methanol to obtain
500 g/ml working standard solution and was used for
optimization of volume of concentrated hydrochloric
acid (conc. HCl) and reaction time for derivatization of
ARM.
2.4.  Optimization  of  reaction  conditions  using  32
full  factorial  design
As ARM does not contain a chromophoric group, it
was derivatized such that the structure of artemether
rearranges and transforms into a UV–visible absorb-
ing compound. Based on a review of the literature,
hydrochloric acid was used as a derivatizing agent for
ARM [30]. Preliminary study was carried out usingderivatization conditions using an experimental design and
first order derivative spectrophotometric method, J. Taibah
0.1 M, 0.5 M, 1 M, and 2 M methanolic HCl at room
temperature and at elevated temperature. In the present
study, it was observed that artemether was not react-
ing with the methanolic HCl at room temperature.
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Table 1
Observed responses in 32 full factorial design with 14 analytical trials.
Run Independent variables Dependent variable
A: volume of
conc. HCl (ml)
B: reaction
time (min)
Absorbance of
ARM (Y)
1 1.3 30 1.41
2 1.3 30 1.40
3 1.6 30 0.90
4 1.3 30 1.40
5 1.0 10 0.68
6 1.6 10 0.50
7 1.3 50 1.41
8 1.0 50 0.93
9 1.3 10 0.77
10 1.3 30 1.40
11 1.3 30 1.41
12 1.0 30 0.92
13 1.3 30 1.40
Intra-day precision was carried out by performing three14 1.6 50 0.89
Hence, it was concluded that concentrated HCl is
required to derivatize ARM at room temperature. The
studies were further carried out using a multivariate
experimental design approach. A three-level full-
factorial design encompassing every possible combina-
tion of factors at the designated levels having five centre
points was used to study two independent variables,
i.e., volume of conc. HCl and reaction time affecting
the derivatization of the ARM. The selection of critical
factors and ranges examined for optimization of deriva-
tization conditions was based on preliminary univariate
studies.
The design domain was constructed as having nine
experimental runs with five centre points with two inde-
pendent variables, volume of conc. HCl (A) and reaction
time (B), and absorbance of ARM was recorded as a
response, as depicted in Table 1. Centre points were
repeated five times to estimate the experimental error.
The investigated range of volume of conc. HCl was
maintained between 1.0 and 1.6 ml while reaction time
between 10 and 50 min. The significance of the rele-
vant factors was calculated using Fisher’s statistical test
for analysis of variance (ANOVA) model, which was
estimated. All experiments were conducted in a random-
ized order to minimize the bias effects of uncontrolled
variables.
2.5.  Ratio  ﬁrst  derivative  spectrophotometric
methodPlease cite this article in press as: J. Christian, et al. Optimizing 
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Stock solutions of 1000 g/ml of ARM and LUM
were prepared by dissolving an accurately weighed PRESS
rsity for Science xxx (2016) xxx–xxx
quantity of 100 mg of stated drugs separately into 100 ml
volumetric flasks; each drug was dissolved and diluted
up to the mark with methanol. Further dilutions were
performed after the addition of the optimized volume
of conc. HCl, and both drugs were allowed to react
with conc. HCl for the optimized reaction time. Sub-
sequently, a working standard solution of 100 g/ml of
ARM and LUM was prepared with appropriate dilution
with methanol.
At increasing concentrations of ARM in methano-
lic HCl, the ratio spectra were computed. Here, the ratio
first order derivative spectra were traced by transforming
zero order spectra by taking λ  = 8 nm and then divid-
ing each absorbance reading by the stored zero order
spectrum of 15 g/ml of LUM. Similarly, the ratio first
order derivative spectra of LUM was recorded by divid-
ing each concentration of LUM by zero order spectrum
of 6 g/ml of ARM using λ  = 8 nm. The wavelength
maxima observed for ARM and LUM was found to be
246.04 nm and 237.47 nm, respectively [51,52].
2.6.  Method  validation
The method was validated with respect to linearity,
accuracy, precision and specificity in accordance with
ICH Q2 (R1) guidelines [53].
2.6.1. Linearity
The linear relationship between concentration and
absorbance of both drugs was evaluated over the concen-
tration range of 5–30 g/ml and 4–12 g/ml for ARM
and LUM, respectively. The linearity ranges for ARM
and LUM were replicated five times. The homoscedas-
ticity of the variances along the regression line of both
drugs was verified using Bartlett’s test [53,54].
2.6.2. Sensitivity
The sensitivity of method was measured in terms
of limit of detection (LOD) and limit of quantification
(LOD). LOD and LOQ of the developed method were
calculated from the standard deviation of the response
(σ) and slope of the calibration curve (S) of each drug
using the formula, limit of detection = 3.3*/S; Limit of
quantitation = 10*/S.
2.6.3.  Precision
The precision of the developed method was evaluated
by performing intra-day and inter-day precision studies.derivatization conditions using an experimental design and
first order derivative spectrophotometric method, J. Taibah
replicates (at morning, afternoon and evening) at three
different concentrations (10, 20 and 30 g/ml for ARM;
4, 8, 12 g/ml for LUM) on the same day, and percent
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elative standard deviation (%RSD) was calculated.
nter-day precision study was assessed by mentioned
oncentrations of ARM and LUM on three different
ays in triplicate, and % RSD was calculated.
.6.4.  Accuracy
To ascertain the accuracy of the proposed method,
ecovery studies were carried out using a standard addi-
ion method by adding a known amount of standard
5, 10 and 15 g/ml for ARM and 2, 4 and 6 g/ml) to
he marketed tablet (10 g/ml ARM and 4 g/ml LUM)
t 50, 100 and 150% level. The mean % recovery was
alculated. Additionally, accuracy was expressed as the
ias, i.e. the difference between the results obtained and
he reference value. Recovery studies were performed in
riplicate [53,55].
.7.  Analysis  of  marketed  formulation
Twenty ARH-L DS tablets (Artemether-80 mg and
umefantrine 480 mg) manufactured by Lincoln Phar-
aceuticals Ltd., Ahmedabad were accurately weighed
nd finely powdered. A quantity equivalent to 25 mg of
RM and 150 mg of LUM was transferred to a 25 ml
olumetric flask and mixed with 15 ml of methanol. The
olution was sonicated for 30 min, and the volume was
ater made up with the same solvent. The solution was
ltered through Whatman filter paper No. 42. Then, 1 ml
ltrate was taken and transferred to another 10 ml vol-
metric flask and further derivatized using optimized
erivatizing conditions, i.e., optimized volume of conc.
Cl (1.3 ml) and reaction time (30 min). Then, volume
as increased to the mark with methanol. For analysis
f both of the above drugs, solution was appropriately
iluted to obtain a concentration of 10 g/ml for ARM
nd 6 g/ml for LUM. Sample solutions were prepared
n triplicate and analyzed according to the procedure
entioned in Section 2.5.
.  Results  and  discussion
The first order ratio derivative spectrophotometric
ethod was developed and validated for the simulta-
eous estimation of ARM and LUM after derivatization
f ARM with hydrochloric acid using an experimental
esign.
.1.  Optimization  of  derivatization  conditionsPlease cite this article in press as: J. Christian, et al. Optimizing 
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.1.1.  Preliminary  studies
ARM quantification is difficult because ARM
acks a chromophoric group. Based on the existing PRESS
rsity for Science xxx (2016) xxx–xxx 5
literature, the derivatization of ARM was accomplished
using hydrochloric acid which yields decomposition
product -  unsaturated decalones, which absorbs
strongly at 254 nm [18]. The reviewed literature shows
that ARM was detected using 0.1 M methanolic HCl as
a derivatizing agent, but it required 3 h of heating at
60 ±  2 ◦C, which again was a time-consuming process.
Thus, in order to derivatize ARM at room temperature,
ARM was derivatized using methanolic hydrochloric
acid, but it was observed that ARM was not detected in
UV at room temperature. Additionally, as molar concen-
tration of methanolic hydrochloric acid increased from
0.1 M to 2 M, UV absorbance was obtained, indicating
the possibility that ARM was not derivatized.
These trials of UV spectroscopy revealed that deriva-
tizing ARM methanolic HCl at room temperature using
the aforementioned molar concentrations was found to
be unsuccessful, but the present study revealed that the
addition of conc. HCl for derivatization of ARM at room
temperature significantly increased the UV absorbance
of ARM. LUM, which has a chromophoric group, may
be analyzed spectrophotometrically. In the simultaneous
estimation of ARM and LUM in the proposed method,
conc. HCl is used as a derivatizing agent. In this experi-
ment, a UV spectrum of LUM was not affected by conc.
HCl, as shown in Fig. 3.
Thus, there was a need to optimize the volume of
conc. HCl and reaction time of conc. HCl with ARM
to produce the acid decomposition product of ARM
(, unsaturated decalone) at room temperature, which
absorbs strongly at 254 nm using 32 full factorial design.
3.1.2. Optimization  of  reaction  conditions  using  32
full  factorial  design
Optimization using a factorial design is a highly effi-
cient and systematic tool that shortens the time required
for the development of method and improves research
and development work. Factorial designs are one of the
major tools used for optimization in which all the studied
factors in all their possible combinations are considered
in order to determine the most efficient factors in esti-
mating the influence of individual variables and their
interactions using minimal experiments [46–50]. The
application of factorial design for optimization of reac-
tion condition has played a key role in understanding the
relationship between the independent variables and the
responses. The independent variables can be controlled,
whereas responses are totally dependent.derivatization conditions using an experimental design and
first order derivative spectrophotometric method, J. Taibah
In this study, the selection of factors examined for
optimization was based on preliminary experiments and
prior knowledge from the literature. A 32 full facto-
rial design was performed using 14 experimental runs,
 IN+Model
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including five centre points. The factors selected for the
optimization process, such as volume of conc. HCl (A)
and reaction time (B), and absorbance of ARM in all
14 design experimental runs are summarized in Table 1.
Experimental results were computed by Design Expert
Trial version 9.0.0.1 software. During model selection,
it was observed that the best-fitted model for absorbance
of ARM was a quadratic model based on lowest PRESS
value and adjusted R2 value nearer to 1.
The model was validated by analysis of variance
(ANOVA) and the results are presented in Table 2. A
value of adequate precision (signal to noise ratio) greater
than 4 is desirable; a value of coefficient of variation
(% CV) (reproducibility of the model) less than 10%
is desirable [56–58]. Fisher F-ratio was used to mea-
sure the significance of the model under investigation
with respect to the variance of all the terms included in
the error term at a P-value equal to 0.05 (Table 2). The
P-value of the model (P-value < 0.05) was in desirable
limits. In this instance, the adjusted R2 values were well
within the acceptable limits of R2 ≥  0.80, indicating that
the experimental data were a good fit to the polynomial
equation (Table 2). The final equation, in terms of actual
components and factors, is shown in Table 2. In this table,
a positive sign indicates a synergistic effect, while a neg-
ative sign indicates an antagonistic effect between factors
and the response.
Additionally, the predicted model is presented in the
form of a perturbation plot for a better understanding of
the results (Fig. 4). This graph provides some idea aboutPlease cite this article in press as: J. Christian, et al. Optimizing 
simultaneous estimation of artemether and lumefantrine by ratio 
Univ. Sci. (2016), http://dx.doi.org/10.1016/j.jtusci.2016.08.003
how the absorbance changes as the volume of conc. HCl
and reaction time changed. Absorbance increases as the
volume of conc. HCl increases, but after a certain level
Fig. 3. (a) UV spectra of LUM in absence of conc. HCl and PRESS
rsity for Science xxx (2016) xxx–xxx
absorbance decreases, even though volume is increased.
However, in relation to reaction time, absorbance ini-
tially increases as the time increases but after a certain
point absorbance value stays constant. From the pertur-
bation plot, it is evident that factor B (reaction time) had
a more significant effect on absorbance value compared
to factor A (volume of conc. HCl).
Fig. 5 shows a 3D response surface plot for the vari-
ation of response as a function of A and B. It depicts
that absorbance increased as the volume of conc. HCl
increased, but only up to a certain volume of conc. HCl.
Afterward, absorbance decreased. Furthermore, in the
case of factor B (reaction time), initially absorbance
increased, but after 30 min, absorbance was constant.
To identify the optimum derivatizing conditions,
numerical optimization in Design Expert software was
attempted by setting various constraints for factors and
responses. According to the criterion set, 10 different
solutions having the desired value of the response were
provided by the software. Among these solutions, two
conditions were selected that had desirability near to 1
or 1. The response surface obtained for the maximum
Derringer’s desirability function is presented in Fig. 6a.
In order to examine the validity of the proposed
model, the agreement between experimental and pre-
dicted responses for both predicted optimums (i.e.,
optimums 1 and 2), as shown in Table 3, was checked,
while the optimum values of the variables were obtained
from the Design-Expert software. The percentage of
prediction error was then calculated using the formuladerivatization conditions using an experimental design and
first order derivative spectrophotometric method, J. Taibah
shown below:
% Predicted error = Experimental −  Predicted
Predicted
×  100
 (b) UV spectra of LUM in presence of conc. HCl.
Please cite this article in press as: J. Christian, et al. Optimizing derivatization conditions using an experimental design and
simultaneous estimation of artemether and lumefantrine by ratio first order derivative spectrophotometric method, J. Taibah
Univ. Sci. (2016), http://dx.doi.org/10.1016/j.jtusci.2016.08.003
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Table 2
Predicted response models and statistical parameters obtained from ANOVA for FFD.
Response Type of
model
Polynomial equation model
for Y
Adjusted
R2
Model
P-value
% CV Adequate
precision
Absorbance of ARM Quadratic −6.99814
+ 11.88A + 0.039B + 5.42 × 10−3AB
− 4.68A2 − 6.05 × 10−4B2
0.9386 <0.0001 7.45 17.577
% CV = coefficient of variance.
Fig. 4. Perturbation plot showing the effect of both factor on absorbance of ARM.
Fig. 5. Response surface methodology plot for study of the effect of volume of conc. HCl and reaction time on absorbance.
Table 3
Comparison of experimental and predictive values of different experimental runs under optimum conditions.
Optimum conditions Volume of conc. HCl (ml) Reaction time (min) Response (absorbance) % Predicted error
Predicted Observed
1 1.3 30 1.390 1.407 1.22
2 1.0 30 1.009 0.925 8.33
ARTICLE IN PRESS+ModelJTUSCI-323; No. of Pages 12
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plot; (bFig. 6. (a) Derringer’s desirability 
The observed value of optimum condition 1 was rel-
atively closer to the predicted value, resulting in less
% predicted error and high desirability as shown in
Fig. 5b, where the graphical optimization displays the
area of feasible response values in the factor space. Thus,
the optimized derivatizing conditions for ARM was
achieved with 1.3 ml volume of conc. HCl and 30 min
of reaction time at room temperature. This resulted in
an optimum absorbance of ARM in UV spectrometry
without affecting the LUM estimation during method
development.
3.2.  Ratio  ﬁrst  derivative  spectrophotometric
method
The standard solutions of ARM and LUM were pre-
pared using the above specified optimized conditions.
The maximum wavelength of absorption was found to be
234 nm and 254 nm for ARM and LUM, respectively, in
zero order overlay spectra after derivatization, as shown
in Fig. 7a. For method development, the zero order
spectrums of 6 g/ml of ARM and 15 g/ml of LUM
were considered as appropriate for the determination of
LUM and ARM, respectively, as divisor. The λ  found
as optimum for the first derivative of their ratio spectra
was 8 nm.
The ratio spectra of different ARM standards ranging
from 5 to 30 g/ml in methanolic HCl were obtained by
dividing each with the zero order spectrum of 15 g/ml
standard solution of LUM, and the first derivative of these
spectra were traced keeping the value of λ  at 8 nm asPlease cite this article in press as: J. Christian, et al. Optimizing 
simultaneous estimation of artemether and lumefantrine by ratio 
Univ. Sci. (2016), http://dx.doi.org/10.1016/j.jtusci.2016.08.003
shown in Fig. 7b and 7c, respectively. Similarly, the ratio
derivative spectra for the solutions of LUM of different
concentration from 2 to 12 g/ml in methanolic HCl
were traced using zero order spectrum of 6 g/ml) Overlay plot for optimum region.
standard solution of ARM as a divisor, as shown
in Fig. 7d and e. From Fig. 7c and e, wavelength
maxima of 246.04 and 237.47 nm were selected for
the determination of ARM and LUM, respectively
[51,52].
3.3.  Method  validation
3.3.1.  Linearity
The calibration range for ARM and LUM was estab-
lished through consideration of the practical range
necessary according to Beer–Lambert’s law. ARM and
LUM showed a good determination coefficient (R2)
between amplitude of ratio spectra and concentration in
range of 5–30 g/ml for ARM and 2–12 g/ml for LUM,
as shown in Table 4. Homoscedasticity of variance was
confirmed by Bartlett’s test and the response of ampli-
tude for both drugs showed homogenous variance that
was exemplified by a χ2 value less than the tabulated
value (Table 4) [53,54].
3.3.2.  Sensitivity
LOD and LOQ were determined based on the stan-
dard deviation of response (intercept) and slope of the
calibration curve according to ICH guideline. LOD
and LOQ of the developed method were found to
be 0.349 and 1.057 g/m, respectively, for ARM and
0.046 and 0.139 g/ml, respectively, for LUM, indicat-
ing the sensitivity of the proposed method (Table 4)
[53].derivatization conditions using an experimental design and
first order derivative spectrophotometric method, J. Taibah
3.3.3.  Precision
The experiment was repeated three times within a
day (intra-day precision) and the average %RSD values
of the results were calculated. Similarly, the experiment
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Fig. 7. (a) Zero order overlay spectra of ARM and LUM; (b) Ratio absorbance spectra of ARM (5–30 g/ml), LUM 15 g/ml as a divisor; (c) Ratio
fi , scaling
6 g/ml), W
w
a
a
f
i
[
3
t
r
A
%
t
m
arst derivative spectra of ARM (5–30 g/ml), Wavelength: 246.04 nm
 g/ml as a divisor; (e) Ratio first derivative spectra of LUM (2–12 
as repeated on three different days (inter-day precision)
nd the average % RSD values for amplitude of ARM
nd LUM were calculated. The developed method is
ound to be precise as the % RSD values for intra-day and
nter-day precision were less than 2% as shown in Table 4
53].
.3.4.  Accuracy
The accuracy of the method was assured by applying
he standard addition technique where good mean
ecoveries were found between 99.96 to 100.49% for
RM while 99.48 to 100.31% for LUM (Table 4).Please cite this article in press as: J. Christian, et al. Optimizing 
simultaneous estimation of artemether and lumefantrine by ratio 
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 RSD values of both drugs were found to be less
han 2% confirming the accuracy of the proposed
ethod. Percentage bias for ARM at 50%, 100%
nd 150% was found to be 0.49, −0.040 and 0.12, factor: 40; (d) ratio absorbance spectra of LUM (2–12 g/ml), ARM
avelength: 237.47 nm, scaling factor: 40.
respectively, while for LUM at 50%, 100% and
150%, it was found to be 0.312, −0.519 and −0.180,
respectively. The accuracy results obtained for ARM
and LUM were within the acceptability criteria for
bias, ±5%, indicating the accuracy of the method
[55].
3.4.  Method  application  in  dosage  form  analysis
The analysis of the marketed tablet exhibited good
recovery of 99.87 ±  1.07% and 99.63 ±  0.73% for
ARM and LUM, respectively with % RSD value lessderivatization conditions using an experimental design and
first order derivative spectrophotometric method, J. Taibah
than 2 indicating that the method can be applicable
in the routine quality control testing of bulk drugs
and for marketed formulations in combined dosage
form.
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Table 4
Analytical parameters of ratio first derivative spectrophotometric
method.
Parameters ARM LUM
Linearitya
Linearity range
(g/ml)
5–30 2–12
Regression
equation
y = 0.217x + 1.723 y = 0.3795x  + 0.303
Determination
coefficient (R2)
0.9990 0.9991
SD of intercepta 0.023 0.005
SD of slopea 0.00089 0.00044
Bartlett’s testb (χ2) 0.0005242 0.000110
Sensitivity
LOD (g/ml) 0.349 0.046
LOQ (g/ml) 1.057 0.139
Precision c (% RSD)
Intra-day precision 0.659–0.371 0.822–0.159
Inter-day precision 0.892–0.421 1.042–0.403
Accuracy d (mean % recovery ± SD)
50% 100.49 ± 0.321 100.31 ± 0.278
100% 99.96 ± 0.341 99.48 ± 0.723
150% 100.12 ± 0.431 99.82 ± 0.319
SD = standard deviation, % RSD = relative standard deviation.
a Average of five determinations.
b Calculated value less than tabulated value, χ2 critical value = 11.1
at 95% confidence interval.
c Average of three determinations for three concentrations.
[
[
[
[
[
[
[16] United States Pharmacopoeia and National Formulary (USP 31-
NF26), US Pharmacopoeia, Rockville, MD, 2008, pp. 683–687.d Average of three determinations at each concentration level.
4.  Conclusions
The proposed method for the simultaneous estima-
tion of artemether and lumefantrine by ratio first order
derivative spectrophotometric method was observed to
be rapid, simple, sensitive, novel, easy and accurate. The
proposed method requires simple measurements and also
facilitates higher values of analytical signals, eliminating
the need of working on zero crossover point. Artemether
strongly lacks absorbing chromophore, so its derivati-
zation with conc. HCl as the derivatizing agent for the
determination by UV spectrophotometer was found to
be very advantageous for routine analysis. Optimization
of the reaction conditions for derivatization were carried
out by 32 full factorial design, which proved suitable for
understanding the relationship between the independent
and dependent variables at every possible combination at
the designated levels. Lumefantrine, which has a chro-
mophoric group, was analyzed spectrophotometrically
in the presence of conc. HCl under optimized condi-
tions for artemether. Hence, the proposed method for thePlease cite this article in press as: J. Christian, et al. Optimizing 
simultaneous estimation of artemether and lumefantrine by ratio 
Univ. Sci. (2016), http://dx.doi.org/10.1016/j.jtusci.2016.08.003
simultaneous estimation of artemether and lumefantrine
is a useful alternative to chromatographic techniques in
[ PRESS
rsity for Science xxx (2016) xxx–xxx
routine analysis of the drugs, decreasing both instrument
cost and time consumption.
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